Goldman Sachs Group Inc Pa Vmed Inc. Transaction History

Goldman Sachs Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 May 14, 2024	BUY	$0.85 - $1.41 $65,416 - $108,513	76,960 New	76,960 $72,000
Q2 2022 Aug 15, 2022	SELL	$0.85 - $1.41 $48,723 - $80,824	-57,322 Reduced 42.69%	76,960 $72,000
Q1 2022 May 16, 2022	SELL	$1.16 - $2.5 $328,763 - $708,542	-283,417 Reduced 67.85%	134,282 $178,000
Q4 2021 Feb 14, 2022	BUY	$2.46 - $8.74 $654,332 - $2.32 Million	265,989 Added 175.33%	417,699 $1.03 Million
Q3 2021 Nov 10, 2021	BUY	$5.1 - $9.39 $773,721 - $1.42 Million	151,710 New	151,710 $1.3 Million

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $92.8M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.